The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Abbott Laboratories
Approval Status: Approved October 1998
Treatment for: Neurology, Pediatrics, Psychiatry
General Information
Treatment for Attention Deficit Disorder